
Join to View Full Profile
55 Lake Ave NWorcester, MA 01655
Phone+1 508-421-1950
Fax+1 623-322-4639
Join Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Thomas Rogers, MD is a board certified pathologist in Worcester, Massachusetts. He is currently licensed to practice medicine in Massachusetts, Florida, and Mississippi. He is affiliated with City of Hope Chicago and is an Assistant Professor at Emory Univ Sch.
Education & Training
- Rhode Island Hospital/Brown University HealthResidency, Pathology-Anatomic and Clinical, 1988 - 1990
- Baylor College of MedicineResidency, Pathology-Anatomic and Clinical, 1986 - 1988
- Baylor College of MedicineResidency, Internal Medicine, 1984 - 1986
- Marshall University School of MedicineInternship, Internal Medicine, 1982 - 1983
- University of Texas Medical Branch School of MedicineClass of 1982
Certifications & Licensure
- FL State Medical License 2025 - 2027
- AZ State Medical License 1984 - 2026
- IL State Medical License 2024 - 2026
- ND State Medical License 2025 - 2026
- TN State Medical License 2024 - 2026
- TX State Medical License 1993 - 2026
- GA State Medical License 2011 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Pathology Anatomic Pathology & Clinical Pathology
- Join now to see all
Publications & Presentations
PubMed
- 38 citationsMetabolic Plasticity of Neutrophils: Relevance to Pathogen Responses and CancerThomas E. Rogers, Ralph J. DeBerardinis
Trends in Cancer. 2021-08-01 - Effectiveness of MB-102, a novel fluorescent tracer agent, for conducting ocular angiography in dogsChristopher G. Pirie, Thomas E. Rogers, Richard B. Dorshow
American Journal of Veterinary Research. 2020-04-28 - 11 citationsCharacterization of MB-102, a New Fluorescent Tracer Agent for Point-of-Care Renal Function Monitoring.Jeng-Jong Shieh, I. Rochelle Riley, Thomas E. Rogers, Lung-Fa Kao, Richard B. Dorshow
Journal of Pharmaceutical Sciences. 2020-02-01